THE TRUTH ABOUT: Allogene rapeutics - The Untold Story

Benzinga's Top Ratings Upgrades, Downgrades For August 10, 2022

 

Benzinga · Aug 10, 2022

What 4 Analyst Ratings Have To Say About Allogene Therapeutics

Analysts have provided the following ratings for Allogene Therapeutics (NASDAQ:ALLO) within the last quarter:

Benzinga · Jun 3, 2022

Allogene Therapeutics Earnings Preview

Allogene Therapeutics (NASDAQ:ALLO) is set to give its latest quarterly earnings report on Wednesday, 2022-02-23. Here's what investors need to know before the announcement. Analysts estimate that Allogene Therapeutics will report an earnings per share (EPS) of $-0.60.

Benzinga · Feb 22, 2022